Showing 551-560 of 3067 results for "".
Women in Aesthetics: Laura Ellis, MD
https://modernaesthetics.com/topics/practice-development/women-in-aesthetics-laura-ellis-md/36085/Get to know Laura Ellis, MD, CEO and Co-Founder of LevEllis Inc.SURGICAL AND NON-SURGICAL AESTHETIC PROCEDURES: THE ERASING DIVIDE
https://modernaesthetics.com/ma-issues-index/2014-sept-oct/surgical-and-non-surgical-aesthetic-procedures-the-erasing-divide/34590/The Promise of Polynucleotides in Targeted DNA Repair for Aesthetic Regeneration
https://modernaesthetics.com/ma-issues-index/jan-feb-2026-issue/the-promise-of-polynucleotides-in-targeted-dna-repair-for-aesthetic-regeneration/54428/Aesthetic Practitioners Should Meet Generation X Where They Are
https://modernaesthetics.com/topics/practice-development/aesthetic-practitioners-should-meet-generation-x-where-they-are/48722/Women In Aesthetics: Katie Cheng, Cynosure
https://modernaesthetics.com/topics/energy-based-devices/women-in-aesthetics-katie-cheng-cynosure/35145/How Generation X Is Shaping Aesthetic Practice Strategies of the Future
https://reachmd.com/programs/modern-aesthetics/how-generation-x-is-shaping-aesthetic-practice-strategies-of-the-future/49008/Women in Aesthetics: Jillian Bridgette Cohen
https://modernaesthetics.com/topics/minimally-invasive/women-in-aesthetics-jillian-bridgette-cohen/34916/Avoiding Complications in Surgical and Nonsurgical Aesthetics
https://modernaesthetics.com/topics/surgical/avoiding-complications-in-surgical-and-nonsurgical-aesthetics/48892/Women In Aesthetics: Helen Fang, CEO of Acclaro Medical
https://modernaesthetics.com/topics/energy-based-devices/women-in-aesthetics-helen-fang-ceo-of-acclaro-medical/35203/The Groundbreaking Original Series from Industry Vet Wendy LewisThey’re Patients, Not Clients: Language as an Ethical North Star in Aesthetic Medicine
https://modernaesthetics.com/topics/practice-development/theyre-patients-not-clients-language-as-an-ethical-north-star-in-aesthetic-medicine/36074/The difference between client and patient is more than a quibble over semantics; it is a barometer of whether we see our work as fundamentally commercial or fundamentally medical.